Sonoma Pharmaceuticals has launched two new products, one in the U.S. for professional care and one in Switzerland for both professional and consumer care, the company said.
OroGenix oral hygiene rinse is Sonoma's second dental product in the U.S. and was developed in partnership with Gabriel Science. In Switzerland, Sonoma and partner Medical Systems Solutions launched Microdacyn oral care for both professional and consumer use.
The products are based on stabilized hypochlorous acid, which has a wide range of applications, including wound, eye, oral, and nasal care, as well as use as a disinfectant and for dermatological conditions, Sonoma said.
